ACTA NEUROPHARMACOLOGICA ›› 2020, Vol. 10 ›› Issue (5): 55-64.DOI: 10.3969/j.issn.2095-1396.2020.05.012

Previous Articles    

Study on the Neuroprotective Mechanism of Quercetin in Alzheimer’s Disease

ZHAO Yu-wei,ZHEN Yan-jie,DAI Yue-ying,SHEN Li-xia   

  1. Department of Pharmacy,Hebei North University,Zhangjiakou,075000,China
  • Online:2020-10-26 Published:2020-10-26
  • Contact: 沈丽霞,女,博士,教授,硕士生导师;研究方向;神经药理学;E-mail:shenlixiacn@163.com
  • About author:赵雨薇,女,硕士研究生;研究方向:神经药理学;E-mail:zhaoyuwei961229@163.com
  • Supported by:
    河北省自然科学基金项目(No.H2019405057);河北省高等学校科学技术技术研究项目(No.ZD2020136)

Abstract:

Alzheimer’s disease (AD) is characterized by progressive cognitive decline and memory loss,and its pathogenesis is complex. At present,no effective drugs and therapeutic approaches have been found clinically to fundamentally prevent and cure AD. Quercetin is a flavonoid phytoestrogen that simulates estrogen stimulation of estrogen receptors to produce weak estrogen activity and has a protective effect on the nervous system. Quercetin has high biological activity,wide source,no teratogenicity,no carcinogenesis,no lethal effect,so it has been widely concerned. In this review,the biological activity of quercetin,its neuroprotective effect on AD and its mechanism of action were reviewed,with a view to providing reference for the research of related drugs for AD.

Key words: Alzheimer’s disease, quercetin, neuroprotective effect